Fractalkine: one chemokine, many functions.

Fractalkine: one chemokine, many functions.

Bibliographic Details
Main Authors:	White, G, Greaves, D
Format:	Journal article
Language:	English
Published:	2009

Similar Items

Fractalkine: a survivor's guide: chemokines as antiapoptotic mediators.
by: White, G, et al.
Published: (2012)

Linked chromosome 16q13 chemokines, macrophage-derived chemokine, fractalkine, and thymus- and activation-regulated chemokine, are expressed in human atherosclerotic lesions.
by: Greaves, D, et al.
Published: (2001)

The transmembrane form of the CX3CL1 chemokine fractalkine is expressed predominantly by epithelial cells in vivo.
by: Lucas, A, et al.
Published: (2001)

The CX3C chemokine fractalkine acts via an extracellular regulated kinase-dependent mechanism to induce human coronary artery smooth muscle cell proliferation
by: White, G, et al.
Published: (2007)

Smooth muscle cells in human atherosclerotic plaques express the fractalkine receptor CX3CR1 and undergo chemotaxis to the CX3C chemokine fractalkine (CX3CL1).
by: Lucas, A, et al.
Published: (2003)

THE CHEMOKINE FRACTALKINE (CX3CL1) HAS ANTI-APOPTOTIC AND PROLIFERATIVE EFFECTS ON PRIMARY HUMAN SMOOTH MUSCLE CELLS VIA EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALLING
by: White, G, et al.
Published: (2009)

Fractalkine promotes human monocyte survival via a reduction in oxidative stress.
by: White, G, et al.
Published: (2014)

Chemokines, chemokine receptors and atherosclerosis
by: John, A, et al.
Published: (2005)

Chemokines and myeloid cell recruitment.
by: Greaves, D, et al.
Published: (2000)

Atherosclerosis: role of chemokines and macrophages.
by: Lucas, A, et al.
Published: (2001)

Abduction of chemokine elements by herpesviruses
by: Dairaghi, D, et al.
Published: (1998)

Expression of a membrane associated CC-chemokine inhibitor protein reduces in vitro macrophage chemotaxis to CC chemokines
by: McNeill, E, et al.
Published: (2010)

Fractalkine has anti-apoptotic and proliferative effects on human vascular smooth muscle cells via epidermal growth factor receptor signalling.
by: White, G, et al.
Published: (2010)

CC chemokine receptors and chronic inflammation--therapeutic opportunities and pharmacological challenges.
by: White, G, et al.
Published: (2013)

Functional somatic syndromes: one or many?
by: Wessely, S, et al.
Published: (1999)

Anti-inflammatory effects of nicotinic acid in adipocytes demonstrated by suppression of fractalkine, RANTES, and MCP-1 and upregulation of adiponectin.
by: Digby, J, et al.
Published: (2010)

Anti-inflammatory effects of nicotinic acid in adipocytes demonstrated by suppression of fractalkine, RANTES, and MCP-1 and upregulation of adiponectin
by: Digby, J, et al.
Published: (2010)

Adenoviral-mediated delivery of a viral chemokine binding protein blocks CC-chemokine activity in vitro and in vivo.
by: Bursill, C, et al.
Published: (2003)

Site-directed mutagenesis of the CC chemokine binding protein 35K-Fc reveals residues essential for activity and mutations that increase the potency of CC chemokine blockade.
by: White, G, et al.
Published: (2011)

Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1).
by: Garton, K, et al.
Published: (2001)

Membrane-bound CC chemokine inhibitor 35K provides localized inhibition of CC chemokine activity in vitro and in vivo.
by: Bursill, C, et al.
Published: (2006)

Anti-inflammatory Effects of Nicotinic Acid: Suppression of Fractalkine, RANTES, and MCP-1 and Upregulation of Adiponectin in 3T3-L1 Adipocytes
by: Digby, J, et al.
Published: (2008)

Alternating-offers bargaining in one-to-many and many-to-many settings
by: An, Bo, et al.
Published: (2016)

The many faces of 'one'
by: Abd Razak, Dzulkifli
Published: (2009)

Chapter One - Using evasins to target the chemokine network in inflammation
by: Bhattacharya, S, et al.
Published: (2019)

A membrane-bound vaccinia viral protein 'mem35k' blocks CC-chemokine induced cell migration and CC-chemokine activity in vitro
by: Bursill, C, et al.
Published: (2005)

Chemokines, chemokine receptors and disease : current topics in membranes /
by: Schwiebert, Lisa M.
Published: (2005)

One world and the many sciences
by: Melnyk, A, et al.
Published: (1990)

Generation and site-directed mutagenesis of a 35K-Fc fusion protein with increased potency of CC chemokine blockade
by: White, G, et al.
Published: (2010)

Novel aspects of chemokine receptor signalling in cardiovascular inflammation
by: Patel, J, et al.
Published: (2018)

The role of chemokines in atherosclerosis: recent evidence from experimental models and population genetics.
by: Bursill, C, et al.
Published: (2004)

Management: one too many styles
by: Mohd Khairuddin Hashim, et al.
Published: (2016)

Management: one too many styles
by: Hashim, Mohd Khairuddin, et al.
Published: (2016)

English : one tongue, many voices /
by: 253994 Svartvik, Jan, et al.
Published: (2006)

Chemokines and viral infection /
by: Lane, T. E.
Published: (2006)

Hydrodynamic gene delivery of CC chemokine binding Fc fusion proteins to target acute vascular inflammation in vivo.
by: McNeill, E, et al.
Published: (2015)

Expression and function of the chemokine receptor CCR7 in thyroid carcinomas.
by: Sancho, M, et al.
Published: (2006)

Chemokine binding to tenascin-C influences chemokine-induced immune cell migration
by: Domaingo, A, et al.
Published: (2023)

Adenoviral mediated delivery of a vaccinia viral protein (35K) blocks CC-chemokine activity in vitro and in vivo and may therefore be a useful therapeutic strategy to reduce the initiation and progression of CC-chemokine induced atherosclerosis
by: Bursill, C, et al.
Published: (2003)

The duffy antigen/receptor for chemokines exists in an oligomeric form in living cells and functionally antagonizes CCR5 signaling through hetero-oligomerization.
by: Chakera, A, et al.
Published: (2008)